Ionis Pharmaceuticals | IONS - Ebitda


Ionis Pharmaceuticals reported $-157.12M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agios Pharmaceuticals USD -115.49M 10.3M Sep/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Astellas Pharma JPY 183.68B 31.98B Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Celltrion KRW 374.56B 352.67B Sep/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Exelixis USD 248.93M 28.02M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -790M 582M Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Neurocrine Biosciences USD 218.4M 28.3M Dec/2025
Novartis USD 5.88B 290M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
OPKO Health USD 75.53M 144.7M Sep/2025
Organigram Holdings CAD 6.15M 455K Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Pharma Mar EUR 44.96M 46.94M Dec/2025
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
Sartorius EUR 277.4M 30.5M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Ultragenyx Pharmaceutical USD -156.79M 65.44M Sep/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025